Moreover, mRNA expression profiling of BRCC3 has been reported in human breast cancer cells, and exogenous BRCC3 expression is associated with delayed death and increased breast cancer cell proliferation[32]. This evidence concerns the gene BRCC3 and breast carcinoma.